Skip to main content

Advertisement

SpringerLink
Log in

Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients With Esophageal Cancer

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Several prognostic factors for patients who have undergone esophagectomy owing to esophageal squamous cell carcinoma have been suggested, including intraoperative blood loss. There are few data, however, suggesting such an association with the prognosis following radical esophagectomy.

Methods

Patients with esophageal squamous cell carcinoma who underwent radical esophagectomy were divided into two groups based on the median value of the intraoperative blood loss (510 g). A multivariate Cox proportional-hazard regression analysis was performed to determine if intraoperative blood loss could be an independent prognostic factor for long-term survival following radical esophagectomy. Kaplan–Meier survival analysis with a log-rank test was performed between the groups.

Results

From April 2005 to May 2009, a total of 37 patients underwent radical esophagectomy for the treatment of esophageal squamous cell carcinoma at the Juntendo Shizuoka Hospital and were assigned either to one of two groups: those with ≥510 g blood loss [bleeding group (BG), n = 19] or of those with <510 g blood loss [less bleeding group (LBG), n = 18]. The distribution of the stage of disease, the number of positive lymph nodes, and the presence of lymphatic and vascular invasion was comparable between the groups, but the Kaplan–Meier survival analysis demonstrated that survival was significantly worse in the BG group than in the LBG group (p = 0.00295). This was supported by the multivariate analysis, which indicated that intraoperative blood loss was independently associated with long-term survival after radical esophagectomy.

Conclusions

Intraoperative blood loss could be a useful prognostic factor following radical esophagectomy in patients with esophageal squamous cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    Article  PubMed  Google Scholar 

  2. Cohen DJ, Ajani J (2011) An expert opinion on esophageal cancer therapy. Expert Opin Pharmacother 12:225–239

    Article  PubMed  Google Scholar 

  3. Demeester SR (2009) Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res 3(Suppl):S2–S5

    PubMed  Google Scholar 

  4. Osugi H, Takemura M, Takada N et al (2002) Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg 89:909–913

    Article  PubMed  CAS  Google Scholar 

  5. Kitagawa Y (2008) Therapeutic strategies for advanced respectable esophageal cancer. Nippon Geka Gakkai Zasshi 109:333–337

    PubMed  Google Scholar 

  6. Higuchi K, Koizumi W, Tanabe S et al (2009) Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 3:153–161

    PubMed  Google Scholar 

  7. Tsurumaru M, Kajiyama Y, Udagawa H et al (2001) Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 7:325–329

    PubMed  CAS  Google Scholar 

  8. Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 72:88–93

    Article  PubMed  CAS  Google Scholar 

  9. Tachibana M, Kinugasa S, Dhar DK et al (1999) Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus. Arch Surg 134:50–54

    Article  PubMed  CAS  Google Scholar 

  10. Hu Y, Zheng B, Rong TH et al (2010) Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy. Chin J Cancer 29:178–183

    PubMed  Google Scholar 

  11. Katz SC, Shia J, Liau KH et al (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623

    Article  PubMed  Google Scholar 

  12. Nagai S, Fujii T, Kodera Y et al (2011) Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas 40:3–9

    Article  PubMed  Google Scholar 

  13. Oefelein MG, Colangelo LA, Rademaker AW et al (1995) Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol 154(Pt 1):442–447

    PubMed  CAS  Google Scholar 

  14. Tartter PI (1992) The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 216:633–638

    Article  PubMed  CAS  Google Scholar 

  15. Ojima T, Iwahashi M, Nakamori M et al (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 13:1821–1830

    Article  PubMed  Google Scholar 

  16. Takemura M, Osugi H, Higashino M et al (2005) Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 11:293–300

    PubMed  Google Scholar 

  17. Tachibana M, Tabara H, Kotoh T et al (1999) Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 94:757–765

    Article  PubMed  CAS  Google Scholar 

  18. Peyre CG, Hagen JA, DeMeester SR et al (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979–985

    Article  PubMed  Google Scholar 

  19. Mariette C, Piessen G, Briez N et al (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371

    Article  PubMed  Google Scholar 

  20. Altorki N, Kent M, Ferrara C et al (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236:177–183

    Article  PubMed  Google Scholar 

  21. Lerut T, Nafteux P, Moons J et al (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome—a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962–972; discussion 972–964

    Article  PubMed  CAS  Google Scholar 

  22. Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47–51

    Article  PubMed  CAS  Google Scholar 

  23. Kobayashi S, Asano T, Ochiai T (2001) A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Hepatogastroenterology 48:372–374

    PubMed  CAS  Google Scholar 

  24. Dhar DK, Kubota H, Tachibana M et al (2000) Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg 24:588–593; discussion 593–584. doi:10.1007/s002689910099

    Article  PubMed  CAS  Google Scholar 

  25. Kamei T, Kitayama J, Yamashita H et al (2009) Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg 33:1240–1246. doi:10.1007/s00268-009-9979-4

    Article  PubMed  Google Scholar 

  26. Bruns CJ, Schafer H, Wolfgarten B et al (1996) Einfluss des intraoperativen Blutverlustes auf die Funktion der naturlichen Killerzellen bei Tumoren des oberen Gastrointestinaltraktes [Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract]. Langenbecks Arch Chir Suppl Kongressbd 113:146–149

    PubMed  CAS  Google Scholar 

  27. Roumen RM, Hendriks T, van der Ven-Jongekrijg J et al (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218:769–776

    Article  PubMed  CAS  Google Scholar 

  28. Cue JI, Peyton JC, Malangoni MA (1992) Does blood-transfusion or hemorrhagic-shock induce immunosuppression. J Trauma 32:613–617

    Article  PubMed  CAS  Google Scholar 

  29. Younes RN, Rogatko A, Brennan MF (1991) The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 214:107–113

    Article  PubMed  CAS  Google Scholar 

  30. Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE (2007) Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 31:2044–2051. doi:10.1007/s00268-007-9159-3

    Article  PubMed  Google Scholar 

  31. Dresner SM, Lamb PJ, Shenfine J et al (2000) Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 26:492–497

    Article  PubMed  CAS  Google Scholar 

  32. Lieberman MD, Shou J, Sigal RK et al (1990) Transfusion-induced immunosuppression results in diminished host survival in a murine neuroblastoma model. J Surg Res 48:498–503

    Article  PubMed  CAS  Google Scholar 

  33. Kaplan J, Sarnaik S, Gitlin J et al (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308–310

    PubMed  CAS  Google Scholar 

  34. Osugi H, Takemura M, Higashino M et al (2003) Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 10:81–87

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Juntendo Shizuoka Hospital, Juntendo University School of Medicine, 1129 Nagaoka, Izunokuni-shi, Shizuoka, 410-2295, Japan

    Yoshihiro Komatsu, Hajime Orita, Mutsumi Sakurada, Hiroshi Maekawa & Koichi Sato

  2. Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Suite 715, 5200 Centre Avenue, Pittsburgh, PA, 15232, USA

    Toshitaka Hoppo

Authors
  1. Yoshihiro Komatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hajime Orita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mutsumi Sakurada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Maekawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshitaka Hoppo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Koichi Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koichi Sato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Komatsu, Y., Orita, H., Sakurada, M. et al. Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients With Esophageal Cancer. World J Surg 36, 844–850 (2012). https://doi.org/10.1007/s00268-012-1433-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-012-1433-3

Keywords

Search

Navigation